Prednisone can protect against exercise-induced muscle damage

Journal of Neurology

Volumn 243, Issue 5, 1996, Pages 410-416

  Jacobs, S C J M ^a   Bootsma, A L ^a   Willems, P W A ^a   Bar P R ^a   Wokke, J H J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Creatine kinase activity; Dystrophin; Exercise; Muscle damage; Prednisone

Indexed keywords

ANTIBODY; BROXURIDINE; CREATINE KINASE; DYSTROPHIN; GLUCOCORTICOID; MYOSIN; PREDNISONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DENSITOMETRY; DOSE RESPONSE; DRUG MEGADOSE; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; EXERCISE; IMAGE ANALYSIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; MORPHOLOGY; MUSCLE FIBER MEMBRANE; MUSCLE INJURY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SATELLITE CELL; SOLEUS MUSCLE; TREADMILL EXERCISE;

ANIMALS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CREATINE KINASE; DRUG EVALUATION, PRECLINICAL; EXERTION; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE FIBERS; MUSCLES; PREDNISONE; RATS; RATS, WISTAR; STRESS, MECHANICAL; WEIGHT GAIN;

EID: 0029988901     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00869001     Document Type: Article

References (42)

1. Adams JC (1981) Heavy metal intensification of DAB-based HRP reaction products. J Histochem Cytochem 29: 775-780
2. Amelink HGJ, Bär PR (1986) Exercise-induced muscle damage in the rat. Effects of hormonal manipulation. J Neurol Sci 76: 61-68
3. Amelink HGJ, Van der Kallen CJH, Wokke JHJ, Bär PR (1990) Dantrolene sodium diminishes exercise-induced muscle damage in the rat. Eur J Pharmacol 179: 187-192
4. Bär PR, Rodenburg AJB, Koot RW, Amelink HGJ (1994) Exercise-induced muscle damage: recent developments. Basic Appl Myol 4: 5-16
5. Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley RT, Miller JP, Kaiser KK, Florence JM, Pandya S, Signore L, King W, Robinson J, Head RA, Province MA, Seyfried W, Mandel P (1987) Clinical investigation of Duchenne muscular dystrophy: interesting results in a trial of prednisone. Arch Neurol 44: 812-817
6. 2: function and pharmacological regulation. Biochem Pharmacol 36: 2429-2436
7. Cullen MJ, Johnson MA, Mastaglia FL (1992) Pathological reactions of skeletal muscle. In: Mastaglia FL, Lord Walton (eds) Skeletal muscle pathology. Churchill Livingstone, London, pp 123-184
8. 2 by lipocortins: an effect of binding to phospholipids. J Biol Chem 262: 1698-1705
9. 2 and Lipocortin effects. In: Meli M, Parente L (eds) Cytokines and lipocortins in inflammation and differentiation. Progress in clinical and biological research, vol 349. Wiley-Liss, New York, pp 47-54
10. Driessen-Kletter MF, Amelink GJ, Bär PR, Van Gijn J (1990) Myoglobin is a sensitive marker of increased muscle membrane vulnerability. J Neurol 237: 234-238
11. Duncan CJ (1989) Dystrophin and the integrity of the sarcolemma in Duchenne muscular dystrophy. Experientia 45: 175-177
12. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345: 315-319
13. Flower RJ (1990) Lipocortin. In: Meli M, Parente L (eds) Cytokines and lipocortins in inflammation and differentiation. Progress in clinical and biological research, vol 349. Wiley-Liss, New York, p 25
14. Flower RJ, Rothwell NJ (1994) Lipocortin-1: cellular mechanism and clinical relevance. Trends Pharmacol Sci 15: 71-76
15. Griggs RC, Moxley RT, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP and the Clinical Investigation of Duchenne Dystrophy Group (1991) Prednisone in Duchenne dystrophy. A randomized controlled trial defining the time course and dose response. Arch Neurol 48: 383-388
16. Griggs RC, Moxley RT, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP, Cwik VA, Pandya S, Robinson J, King W, Signore L, Schierbecker J, Florence J, Matheson-Burden N, Wilson B (1993) Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months). Neurology 43: 520-527
17. Hardiman O, Sklar RM, Brown RH (1993) Methylprednisolone selectively affects dystrophin expression in human muscle cultures. Neurology 43: 342-345
18. Ibraghimov-Breskovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696-702
19. Jacobs SCJM, Wokke JHJ, Bär PR, Bootsma AL (1995) Satellite cell activation after muscle damage in young and adult rats. Anat Rec 242: 329-336
20. Karpati G, Carpenter SC (1988) The deficiency of a sarcolemmal cytoskeletal protein (dystrophin) leads to necrosis of skeletal muscle fibers in Duchenne-Becker dystrophy. In: Sellin LS, Libellius R, Thesloff S (eds) Neuromuscular junction. Elsevier, Amsterdam, pp 429-436
21. Kelly FJ, McGrath JA, Goldspink DF, Cullen MJ (1986) A morphological/biochemical study on the actions of corticosteroids on rat skeletal muscle. Muscle Nerve 9: 1-10
22. Khan MA (1993) Corticosteroid therapy in Duchenne muscular dystrophy. J Neurol Sci 120: 8-14
23. Kissel JT, Lynn DJ, Rammohan KW, Klein JP, Griggs RC, Moxley RT, Cwik VA, Brooke MH, Mendell JR (1993) Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy. Neurology 43: 532-536
24. Komulainen J, Vihko V (1994) Exercise-induced necrotic muscle damage and enzyme release in the four days following prolonged submaximal running in rats. Pflugers Arch 428: 3-4
25. Kuipers H, Drukker J, Frederik PM, Geurten P, Van Kranenburg G (1983) Muscle degeneration after exercise in rats. Int J Sports Med 4: 45-51
26. Luo VJ, Murphy LJ (1989) Dexamethasone inhibits growth induction of insulin-like growth factor (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat. Endocrinology 125: 165-171
27. Matsumura K, Campbell KP (1994) Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17: 2-15
28. McLean IW, Nakane PK (1974) Periodate-lysine-paraformaldehyde fixative. A new fixative for immunoelectron microscopy. J Histochem Cytochem 22: 1077-1083
29. McNeil PL (1993) Cellular and molecular adaptations to injurious mechanical stress. Trends Cell Biol 3: 302-307
30. Mendell JR, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, King W, Signore L, Pandya S, Florence J, Schierbecker J, Robison J, Kaiser K, Mandel S, Arfken G, Gilder B (1989) Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 320: 1592-1597
31. Menke A, Jockusch H (1991) Decreased osmotic stability of dystrophinless muscle cells from mdx mouse. Nature 349: 9-71
32. Moxley RT, Lorenson M, Griggs RC, Mendell JR, Fenichel GM, Brooke MH, Miller JP, and CIDD group (1990) Decreased breakdown of muscle protein after prednisone therapy in Duchenne dystrophy (DD). J Neurol Sci 98: 419
33. Nicholson LVB, Johnson MA, Gardner-Medwin D, Bhattacharya S, Harris JB (1989) Heterogeneity of dystrophin expression in patients with Duchenne and Becker muscular dystrophy. Acta Neuropathol (Berl) 80: 239-250
34. Ohlendieck K, Matsumura K, Ionasescu VV, Towbin JA, Bosch EP, Weinstein SL, Sernett SW, Campbell KP (1993) Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology 43: 795-800
35. Paget GE, Barnes JM (1964) Toxicity test. In: Bacharach L (ed) Evaluation of drug activities: pharmacometrics. Academic Press, London, pp 161
36. Pasternak C, Wong S, Elson EL (1992) The mechanical function of dystrophin in muscle cells. Mol Biol Cell 192a: Suppl 192a : 1111
37. Sklar RM, Brown RH (1991) Methylprednisolone increases dystrophin levels by inhibiting myotube death during myogenesis of normal human muscle in vitro. J Neurol Sci 101: 73-81
38. Turner PR, Westwood T, Regen CM, Steinhardt RA (1989) Increased protein degradation results from elevated free calcium levels found in muscle from MDX mice. Nature 335: 735-738
39. Van de Kant HJG, De Rooij DG (1992) Periodic acid incubation can replace hydrochloric acid hydrolysis and trypsin digestion in immunogold-silver staining of bromodeoxyuridine incorporation in plastic sections and allows the PAS reaction. Histochem J 24: 170-175
40. 2: protection of membranes from lipid peroxidation damage. Trends Biochem Sci 12: 31-34
41. Vane J, Bolting R (1987) Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J 1: 89-96
42. Weller B, Karpati G, Carpenter S (1990) Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J Neurol Sci 100: 9-13